Xylem Inc.
XYL
$120.75
$0.870.73%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.69% | -1.43% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.69% | -1.43% | |||
| Cost of Revenue | 5.78% | -1.70% | |||
| Gross Profit | 5.55% | -1.01% | |||
| SG&A Expenses | 2.73% | -5.56% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.28% | -2.94% | |||
| Operating Income | 7.89% | 7.58% | |||
| Income Before Tax | 23.91% | -0.67% | |||
| Income Tax Expenses | -50.70% | -5.33% | |||
| Earnings from Continuing Operations | 47.35% | 0.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 100.00% | -50.00% | |||
| Net Income | 47.58% | 0.44% | |||
| EBIT | 7.89% | 7.58% | |||
| EBITDA | 5.84% | 4.63% | |||
| EPS Basic | 47.54% | 0.42% | |||
| Normalized Basic EPS | 8.23% | 9.24% | |||
| EPS Diluted | 47.26% | 0.16% | |||
| Normalized Diluted EPS | 8.19% | 9.18% | |||
| Average Basic Shares Outstanding | 0.02% | 0.02% | |||
| Average Diluted Shares Outstanding | 0.06% | 0.08% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.32% | -0.01% | |||